Search Results 1401-1410 of 10710 for colchicine
This medicine may increase your chance of having blood clotting problems (eg, venous thrombosis, pulmonary embolism, myocardial infarction, and stroke). Tell ...
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.
The primary purpose of this study is to select and validate candidate methylated DNA markers (MDMs) (individually and in combined panels) for the detection ...
2003. Fellow - Neonatal and Developmental MedicineLucile Salter Packard Children's Hospital at Stanford · 2003. Research FellowshipDepartment of Pediatrics and ...
The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma that has ...
Bromfenac ophthalmic (eye) solution is used to treat pain or swelling of the eye following cataract surgery. This medicine is a topical nonsteroidal anti- ...
The purpose of the study is to learn more about autoimmunity and potential mother to baby transmission of pathogenic antibodies.
Rochester, Minn. This is a survey study to describe how women with Lynch syndrome are being screened for gynecologic cancer risk, their perception of cancer ...
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
Approximately 358 patients will be randomized in a 1:1 ratio to DCC-2618 150 mg once daily (QD) (continuous dosing for 6 week cycles) or sunitinib 50 mg QD (6 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.